Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII

Acquired hemophilia A (AHA) is a rare autoimmune disorder caused by autoantibodies against Factor VIII (FVIII). It has a high mortality due to bleeding complications. FVIIa-based bypassing agents are the first line of treatment but not always effective. Recombinant porcine (rp) FVIII (Obizur®) was r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, S., Teh, P., Zhou, J., Chang, E. Y., von Drygalski, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735189/
https://www.ncbi.nlm.nih.gov/pubmed/31559096
http://dx.doi.org/10.1155/2019/9026121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735189/
https://www.ncbi.nlm.nih.gov/pubmed/31559096
http://dx.doi.org/10.1155/2019/9026121

Ejemplares similares